AzTrials
AzTrials

Shift-work DisorderNCT05153759

EMS Providers' Health Initiative Study

A study testing Meal service in people with Shift-work Disorder, run by State University of New York at Buffalo at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to explore dietary factors that influence glycemic control in night shift EMS providers and to test the feasibility of a dietary intervention among these providers. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Shift-work Disorder
What is being tested?
Meal service
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteUnited States
Study dates
7 Jun 2022to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Emergency medical service (EMS) provider
  • Works night shift only for at least one year
  • Provides patient care as primary duty

Who cannot join

  • Diagnosis of a metabolic disease (i.e. diabetes, prediabetes, metabolic syndrome)
  • Taking medication to lower blood glucose
  • Pregnant or planning to become pregnant
  • Diagnosis of kidney disease or impairment
  • Allergies or intolerances to study foods
  • Digestive disorder

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Tegan H Mansouri, PhD contact

716-829-5596

teganman@buffalo.edu

Jocelyn Stooks, MS contact

716-829-5596

jstooks@buffalo.edu

United States1 site, 1 recruiting
  • University at Buffalo

    Buffalo, New York, 14214

    David Hostler, PhD, 716-829-6795, dhostler@buffalo.edu

    Tegan Mansouri, PhD

    Recruiting

Other trials in United States

About this study

This study aims to explore dietary factors that influence glycemic control in night shift EMS providers and to test the feasibility of a dietary intervention among these providers.

Read the detailed description

This study can be broken down into two phases. Both phases will take place over the course of 3 weeks. During the first week, participants will be scheduled for a single 60-90 minute zoom appointment. During this appointment, informed consent will be obtained, participants will provide health and demographic information, complete several questionnaires, and be familiarized with study protocols. The following week, participants will wear a continuous glucose monitor, actigraph activity monitor, document everything they have to eat and drink, and rate their daily stress levels. Participants will continue this during the final week and will be randomized to consume either a 2:1 or 1:1 protein to carbohydrate ratio during the night shift during this week.

Being tested
Meal service
Keywords
EMS, Night shift, Nutrition, Insulin resistance, Circadian rhythm
Medical subject headings
Insulin Resistance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Meal serviceOther

    The primary goal is to pilot the feasibility of a meal service intervention in night shift workers

Study groups in NCT05153759
Study groupRoleWhat they receive
High proteinActive comparatorConsuming a meal composed of 2:1 grams of protein to carbohydrate during the night shift between 7pm-7am
Receives: Other: Meal service
Moderate proteinPlacebo comparatorConsuming a meal composed of 1:1 grams of protein to carbohydrate during the night shift between 7pm-7am
Receives: Other: Meal service

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Glycemic control

    Daily mean blood glucose

    Measured: Two weeks

  2. Compliance

    Percent of participants who adhere to the dietary intervention

    Measured: Four days

Secondary outcomes (1)
  1. Perceived stress

    Daily rating of stress on a scale of one to 10 where 10 is the most stressed the participant has ever been

    Measured: Two weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Dec 2021
  2. Study start7 Jun 2022
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05153759
Sponsor's protocol ID
EMS Health
Status last verified
Jan 2026
First submitted
29 Nov 2021
Last updated
27 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPD will be de-identified and kept in a password protected database (REDcap.com)

Questions about this trial

What is this clinical trial studying?

A study testing Meal service in people with Shift-work Disorder, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 27 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tegan H Mansouri, PhD (716-829-5596, teganman@buffalo.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Glycemic control (time frame: Two weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in